Revenue Growth YoY (Last 12 Months): Amneal Pharmaceuticals (AMRX)

Brandmark of Amneal Pharmaceuticals (AMRX)

The annual change in LTM sales volume demonstrates the market dynamics of Amneal Pharmaceuticals (AMRX), with 9.10 representing the latest level. High barriers to entry are driven by strict FDA oversight and the high cost of sterile manufacturing facilities. Growth is based on increasing pipeline volumes to reduce drug production costs. A mature generics portfolio ensures a stable cash flow, supporting the accessibility of basic therapy.

Amneal Pharmaceuticals (AMRX) - Sales Growth YoY (TTM) from 02/11/2024 to 11/18/2026

Summary analytical data breakdowns for Amneal (AMRX)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company valuation:Amneal Corp
Original product of amneal.com

This indicator measures fundamental revenue dynamics by excluding short-term reporting volatility. Analyzing the year-over-year sales trend over the last 12 months allows for an assessment of the business's real expansion rate. The calculation is based on a rolling annual window, which smooths out seasonal fluctuations and information noise. A positive vector here confirms the effectiveness of the Amneal Pharmaceuticals (AMRX) management strategy regarding the introduction of complex biosimilars and injectable drugs.

Competitors of Amneal Pharmaceuticals (AMRX)

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|Sales Growth YoY (Last Twelve Months) Perrigo Company|Trailing Twelve Months Revenue Growth Alvotech ALVO|Sales Growth YoY (TTM) LQDA|GLPG: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ANIP (ANI Pharmaceuticals, Inc.)|Annual Revenue Growth (Last Twelve Months) MannKind Corp (MNKD)|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)